Results
|
541.
|
|
|
542.
|
|
|
543.
|
Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study. [electronic resource] by
- Yamada, K
- Furusawa, S
- Saito, K
- Waga, K
- Koike, T
- Arimura, H
- Aoyagi, A
- Yamato, H
- Sakuma, H
- Tsunogake, S
Producer: 19950306
In:
Leukemia vol. 9
Availability: No items available.
|
|
544.
|
|
|
545.
|
Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline. [electronic resource] by
- Fukushima, Toshihiro
- Kawabata, Hiroshi
- Sawaki, Toshioki
- Satoh, Tomomi
- Nakamura, Takuji
- Iwao, Haruka
- Nakajima, Akio
- Sakai, Tomoyuki
- Miki, Miyuki
- Fujita, Yoshimasa
- Tanaka, Masao
- Kawanami, Takafumi
- Masaki, Yasufumi
- Okazaki, Toshiro
- Umehara, Hisanori
Producer: 20120524
In:
Anticancer research vol. 32
Availability: No items available.
|
|
546.
|
|
|
547.
|
|
|
548.
|
|
|
549.
|
[Acute myelogenous leukemia with multilineage myelodysplasia, positive direct Coombs test, and elevated levels of platelet-associated IgG]. [electronic resource] by
- Kuroda, Hiroyuki
- Matsunaga, Takuya
- Sakamaki, Sumio
- Koike, Kazuhiko
- Terui, Takeshi
- Neda, Hiroshi
- Ishitani, Kunihiko
- Nobuoka, Atsushi
- Kida, Masaya
- Watanabe, Hideki
- Niitsu, Yoshiro
Producer: 20070727
In:
[Rinsho ketsueki] The Japanese journal of clinical hematology vol. 48
Availability: No items available.
|
|
550.
|
[The efficacy and safety of HAA regimen as induction chemotherapy in 150 newly diagnosed acute myeloid leukemia]. [electronic resource] by
- Song, Yan-ping
- Tong, Yin
- Qian, Wen-bin
- Mai, Wen-yuan
- Meng, Hai-tao
- Qian, Ji-jing
- Tong, Hong-yan
- Huang, Jian
- Mao, Li-ping
- Xu, Wei-lai
- Jin, Jie
Producer: 20111219
In:
Zhonghua nei ke za zhi vol. 50
Availability: No items available.
|
|
551.
|
|
|
552.
|
|
|
553.
|
|
|
554.
|
|
|
555.
|
|
|
556.
|
Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia. [electronic resource] by
- Liu, Limin
- Zhang, Yanming
- Jin, Zhengming
- Zhang, Xingxia
- Zhao, Guangsheng
- Si, Yejun
- Lin, Guoqiang
- Ma, Aidi
- Sun, Yingxin
- Wang, Li
- Wu, Depei
Producer: 20150413
In:
International journal of hematology vol. 99
Availability: No items available.
|
|
557.
|
|
|
558.
|
|
|
559.
|
|
|
560.
|
|